Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.40USD
21 Aug 2018
Change (% chg)

-- (--)
Prev Close
$15.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,957
52-wk High
$20.55
52-wk Low
$7.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.50 -0.663
Mar '18 0.00 -0.686
FY 2017 Dec '17 0.00 -0.925
Sep '17 0.30 -0.684
Jun '17 0.30 -0.660
Mar '17 0.30 -0.668
FY 2016 Dec '16 0.30 -0.560
Sep '16 0.30 -0.557
Jun '16 0.24 -0.524
Mar '16 0.21 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.04 0.20 0.00 0.15
Quarter Ending Dec-18 5 0.41 2.06 0.00 37.95
Year Ending Dec-18 5 0.95 2.76 0.50 35.59
Year Ending Dec-19 5 60.81 135.00 9.70 72.32
Earnings (per share)
Quarter Ending Sep-18 5 -0.67 -0.64 -0.71 -0.54
Quarter Ending Dec-18 5 -0.76 -0.65 -0.97 0.55
Year Ending Dec-18 5 -2.77 -2.63 -3.04 -0.99
Year Ending Dec-19 5 -0.91 1.54 -2.37 -0.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.69 32.76
P/E High - Last 5 Yrs. -- 300.66 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -0.12 0.93 0.89
Price to Sales (TTM) 252.25 114.99 5.75
Price to Book (MRQ) 3.76 15.52 5.00
Price to Tangible Book (MRQ) 3.78 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 49.44 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 26.38 411.56 8.01
Sales (TTM) vs TTM 1 Yr. Ago 40.26 80.51 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.96 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -14.13 -- --
EPS - 5 Yr. Growth Rate -- 39.85 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 4.65 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.36 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -4,219.92 -- --
EBITD - 5 Yr. Avg -6,446.46 -600.69 10.68
Operating Margin (TTM) -4,220.23 -759.79 4.32
Operating Margin - 5 Yr. Avg. -6,468.54 -621.72 6.11
Pre-Tax Margin (TTM) -4,171.16 -733.64 5.18
Pre-Tax Margin - 5 Yr. Avg. -6,417.04 -627.42 6.51
Net Profit Margin (TTM) -4,171.28 -735.01 1.48
Net Profit Margin - 5 Yr. Avg. -6,415.84 -630.47 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,297 23,231,105 860,375,625
Net Income/Employee (TTM) -1,722,596 3,144,294 101,207,245
Receivable Turnover (TTM) 19.87 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.01 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.70 -0.16 11.13
Return on Assets - 5 Yr. Avg. -47.10 3.51 12.40
Return on Investment (TTM) -65.15 1.78 14.61
Return on Investment - 5 Yr. Avg. -52.69 2.56 16.13
Return on Equity (TTM) -65.34 3.28 16.33
Return on Equity - 5 Yr. Avg. -53.70 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 59.19 144.78 --
EPS (TTM) % 0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stemline Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.17%
# of Holders: 128
Total Shares Held: 20,804,968
3 Mo. Net Change: 1,462,552
# New Positions: 22
# Closed Positions: 19
# Increased Positions: 70
# Reduced Positions: 43
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.